Abstract:BackgroundPortal hypertension is a key complication of portal hypertension, which is responsible for the development of varices, ascites, bleeding, and hepatic encephalopathy, which, in turn, cause a high mortality and requirement for liver transplantation.AimThis review deals with the present day state-of-the-art preventative treatments of portal hypertension in cirrhosis according to disease stage. Two main disease stages are considered, compensated and decompensated cirrhosis, the first having good prognosis and being mostly asymptomatic, and the second being heralded by the appearance of bleeding or non-bleeding complications of portal hypertension.ResultsThe aim of treatment in compensated cirrhosis is preventing clinical decompensation, the more frequent event being ascites, followed by variceal bleeding and hepatic encephalopathy. Complications are mainly driven by an increase of hepatic vein pressure gradient (HVPG) to values ≥10 mmHg (defining the presence of Clinically Significant Portal Hypertension, CSPH). Before CSPH, the treatment is limited to etiologic treatment of cirrhosis and healthy life style (abstain from alcohol, avoid/correct obesity…). When CSPH is present, association of a non-selective beta-blocker (NSBB), including carvedilol should be considered. NSBBs are mandatory if moderate/large varices are present. Patients should also enter a screening program for hepatocellular carcinoma. In decompensated patients, the goal is to prevent further bleeding if the only manifestation of decompensation was a bleeding episode, but to prevent liver transplantation and death in the common scenario where patients have manifested first non-bleeding complications. Treatment is based on the same principles (healthy life style..) associated with administration of NSBBs in combination if possible with endoscopic band ligation if there has been variceal bleeding, and complemented with simvastatin administration (20-40 mg per day in Child–Pugh A/B, 10–20 mg in Child C). Recurrence shall be treated with TIPS. TIPS might be indicated earlier in patients with: 1) Difficult/refractory ascites, who are not the best candidates for NSBBs, 2) patients having bleed under NSBBs or showing no HVPG response (decrease in HVPG of at least 20% of baseline or to values equal or below 12 mmHg). Decompensated patients shall all be considered as potential candidates for liver transplantation.ConclusionTreatment of portal hypertension has markedly improved in recent years. The present day therapy is based on accurate risk stratification according to disease stage.

A Case of Gastric Cardia Telangiectasias and Primary Biliary Cirrhosis with Hemorrhage

Should Vasoconstrictors Be Considered in a Cirrhotic Patient with Acute Non-variceal Upper Gastrointestinal Bleeding?

Hepatocellular carcinoma and upper gastrointestinal bleeding

Woman With Hematochezia

Diagnosis and Treatment of Upper Gastrointestinal Hemorrhage Caused by Pancreatic Segmental Portal Hypertension

Acute Pancreatitis Associated Left-Sided Portal Hypertension with Severe Gastrointestinal Bleeding Treated by Transcatheter Splenic Artery Embolization: a Case Report and Literature Review

Diagnosis and Management of Gastrointestinal Bleeding Caused by Pancreatic Sinistral Portal Hypertension

Portal Hypertension Resulted from Paroxysmal Nocturnal Hemoglobinuria: a Case Report and Review of Literature.

A Case of Agnogenic Intrahepatic Arterioportal Fistula Complicated by Gastric Ulcer Bleeding and Progressive Portal Thrombosis

Gastrointestinal bleeding due to pancreatic metastasis of non-small cell lung cancer: A report of two cases and a literature review

The portal hypertension syndrome: etiology, classification, relevance, and animal models

Esophageal Varices Presenting With Massive Hematemesis in a Chronic Alcoholic: A Case Report on a Rare Condition

Splenectomy And Selectively Devascularization For Esophageal Bleeding Secondary To Portal Hypertension

Asymptomatic Extrahepatic Portal Venous Obstruction: A Case Report

Degradation of iprodione by a soil Arthrobacter-like strain

Acute upper gastrointestinal bleeding due to portal hypertension in a patient with primary myelofibrosis: A case report

Sinistral Portal Hypertension Due to a Pancreatic Pseudocyst: A Rare Cause of Upper Gastrointestinal Bleeding

S3663 Splenic Variceal Bleeding Presenting With Hemorrhagic Shock in Cirrhosis

Characteristics of peptic ulcer bleeding in cirrhotic patients with esophageal and gastric varices

S4548 A Case of Variceal Bleeding Post-Whipple in a Patient Without Cirrhosis

Case report: Rapid development of acute symptomatic portal vein system thrombosis after endoscopic variceal therapy in a patient with liver cirrhosis